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Abstract
Let-7 miRNAs comprise one of the largest and most highly expressed family of miRNAs
among vertebrates, and is critical for promoting differentiation, regulating metabolism, inhibit-
ing cellular proliferation, and repressing carcinogenesis in a variety of tissues. The large size
of the Let-7 family of miRNAs has complicated the development of mutant animal models.
Here we describe the comprehensive repression of all Let-7 miRNAs in the intestinal epithe-
lium via low-level tissue-specific expression of the Lin28bRNA-binding protein and a condi-
tional knockout of theMirLet7c-2/Mirlet7b locus. This ablation of Let-7 triggers the
development of intestinal adenocarcinomas concomitant with reduced survival. Analysis of
both mouse and human intestinal cancer specimens reveals that stem cell markers were sig-
nificantly associated with loss of Let-7 miRNA expression, and that a number of Let-7 targets
were elevated, including Hmga1 and Hmga2. Functional studies in 3-D enteroids revealed
that Hmga2 is necessary and sufficient to mediate many characteristics of Let-7 depletion,
namely accelerating cell cycle progression and enhancing a stem cell phenotype. In addition,
inactivation of a single Hmga2 allele in the mouse intestine epithelium significantly represses
tumorigenesis driven by Lin28b. In aggregate, we conclude that Let-7 depletion drives a
stem cell phenotype and the development of intestinal cancer, primarily via Hmga2.
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Author Summary
Cancer develops following multiple genetic mutations (i.e. in tumor suppressors and onco-
genes), and mutations that cooperate or synergize are often advantageous to cancer cell
growth. To study how multiple genes might cooperate, it is usually informative to generate
candidate mutations in cells or in mice. Large gene families, such as the Let-7 family, are
difficult to silence or mutate because of the large amount of redundancy that exists
between similar copies of the same gene; the mutation of one will often be masked or com-
pensated by the continued function of others. In the mouse intestine we have achieved
comprehensive depletion of all Let-7 miRNAs in this large multi-genic family through use
of an inhibitory protein, called LIN28B, that specifically represses Let-7, and genetic inacti-
vation of another gene cluster calledMirLet7c-2/Mirlet7b. Mice with this comprehensive
depletion of Let-7 develop intestinal cancers that resemble human colon cancers. Our fur-
ther analysis identified another gene, HMGA2, downstream of this pathway that is critical
to this outcome.
Introduction
Micro-RNAs (miRNAs) are critical for tumor suppression, which is most notably revealed fol-
lowing genetic manipulation of Dicer1, an enzyme needed for miRNA processing, in which
haplo-insufficiency of Dicer1 and global reduction of miRNA levels significantly accelerates
tumorigenesis [1,2]. Let-7 miRNAs comprise one of the largest and most highly expressed fam-
ilies of miRNAs, possessing potent anti-carcinogenic properties in a variety of tissues [3]. This
activity is likely mediated via Let-7 repression of a multitude of onco-fetal mRNAs and other
pro-proliferative and/or pro-metastatic targets, such as HMGA2, IGF2BP1, IGF2BP2, and
NR6A1 [4–6]. Let-7 biogenesis is tightly regulated, revealed by the discovery of several proteins
that regulate processing by DGCR8/DROSHA in the nucleus, and by DICER1 cleavage in the
cytoplasm. Most notable are LIN28A and LIN28B, which are RNA-binding proteins that
directly bind to and block the processing of Let-7 mRNAs [7,8]. LIN28A works in concert with
TRIM25 and TUT4 to mediate terminal uridylation and subsequent degradation of immature
precursor-Let-7 (pre-Let-7) miRNA molecules [9–11]. LIN28B appears to act by sequestering
primary-Let-7 (pri-Let-7) miRNAs within the nucleolus to prohibit processing by DGCR8 and
DROSHA [9]. The critical nature of maintaining sufficient levels of mature Let-7 miRNAs is
reflected in the large number of studies that have found LIN28A or LIN28B up-regulated in
human cancers, with expression often associated with an aggressive disease phenotype and/or
predictive of poor outcomes [12–15]. LIN28B appears somewhat more frequently up-regulated
than LIN28A in cancer, and may reflect the greater expression potential of LIN28B in adult tis-
sues: LIN28B exhibits a later temporal pattern of expression in adult tissues such as the intes-
tine, plays a greater role in post-natal growth, and can be re-activated by inflammation and
NF-kappa-B [16–19].
In efforts of The Cancer Genome Atlas (TCGA) research consortia to define miRNA-mRNA
associations across multiple different cancers (i.e. the pan-cancer initiative), the LIN28B:Let-7b
interaction was identified as one of the most significant relationships discovered across nine dif-
ferent human malignancies [20]. The tight functional interplay between LIN28 proteins and
Let-7 is delineated clearly, on biochemical and biological levels. However, Let-7 action appears
dependent on the particular mRNA targets affected, although Let-7 represses de-differentiation
in multiple contexts. For example, Let-7 regulates insulin-PI3K-mTOR signaling in muscle by
inhibiting expression of INSR, IGF1R, and IRS2 [21], yet can also inhibit mTORC1 without
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affecting insulin-PI3K signaling [22], whereas we have observed no effects on insulin-PI3K-
mTOR signaling following depletion of Let-7 miRNAs in the small intestine [18]. Micro-RNAs
have many targets, including both coding and non-coding mRNAs, and to address the func-
tional impact of these miRNAs, one must dissect the cascade of integrated signals that ensue fol-
lowing alterations of a miRNA. Many studies have focused on RAS andMYC as cancer-relevant
Let-7 targets, although recent high-throughput sequencing (mRNA-seq, miRNA-seq, and
CLIP-seq) and meta-analyses indicate that these mRNA targets are not frequently regulated by
Let-7, especially in the context of cancer [5,6,20,23]. Onco-fetal Let-7 targets such asHMGA2
and IGF2BP1-3 appear to be more frequently up-regulated in multiple contexts, across multiple
tissues, and in association with somatic stem cell potential [4,5,20,24–29].
We have demonstrated that LIN28B is a potent driver of colorectal cancer (CRC) progres-
sion, cellular invasion, and in mouse models, a regulator of intestinal growth and tumorigenesis
[15,18,30]. The exploration of Let-7-dependence through genetic manipulation in mouse mod-
els is currently untenable due to the large number of miRNA clusters, with 12 Let-7 genes
located at 8 separate clusters on 7 different chromosomes. To circumvent this obstacle and elu-
cidate the mechanistic roles of Let-7 miRNAs in intestinal tumorigenesis in a genetic mouse
model we have combined a Vil-Lin28bLow (Lin28bLo) transgene with intestinal deletion of the
MirLet7c-2/Mirlet7b bi-cistronic cluster (Let-7IEC-KO) to achieve robust repression of all Let-7
miRNAs expressed in the intestinal epithelium. Concurrent deletion of theMirLet7c-2/Mir-
let7b bi-cistronic cluster is necessary as Lin28b is unable to effectively target and inhibit pro-
cessing of these specific Let-7 miRNAs [18].
These Lin28bLo/Let-7IEC-KO mice develop intestinal polyps with 100% penetrance and
develop adenocarcinomas in the majority of animals, coincident with reduced survival. Exami-
nation of Let-7 targets in these tumors and in tumoroid cultures suggest that HMGA2 is likely
playing a major role in driving carcinogenesis following Let-7 depletion, a novel in vivo finding.
Furthermore, we find that tumorigenesis and a stem cell signature are driven by Let-7 depletion
in mouse and human intestinal tumors, in which HMGA2 appears to play a functional role in
reinforcing.
Results
Comprehensive Depletion of Let-7 miRNAs Leads to the Development
of Intestinal Adenocarcinomas in Mice
Vil-Lin28bLow mice and Let7IEC-KO mice were generated and described previously [18]. To gen-
erate compound mutant animals we used a low-expressing transgenic line (Lin28bLo), in which
we could not detect measureable changes in either protein or mRNA levels of Let-7-indepen-
dent Lin28b targets [18]. These compound Lin28bLo/Let7IEC-KO mice, exhibit depletion of all
Let-7 miRNAs specifically in intestinal epithelial cells (IEC) achieved through deletion of the
MirLet7c-2/MirLet7b locus and repression of all other Let-7 miRNAs through inhibition by
Lin28b [18] (and Fig 1A). Lin28bLo/Let7IEC-KO mice thrived initially, with normal behavior and
weight gain, but displayed significantly increased mortality and morbidity starting around 6
months of age, whereas neither Vil-Lin28bLo nor Let7IEC-KO age-matched mice exhibited any
overt phenotype (Fig 1B). Surviving Lin28bLo/Let7IEC-KO were sacrificed between 10 and 14
months of age and exhibited a significant incidence of adenomas and adenocarcinomas,
restricted to the small intestine, with an average of 2.86 lesions per mouse and 100% penetrance
(S1 Table and Fig 1C, 1D and 1E). Six of seven Lin28bLo/Let7IEC-KO mice developed invasive
adenocarcinoma (S1 Table and Fig 1C, 1D and 1E). Tumors from mice also displayed nuclear
localization of β-catenin (Fig 1F), indicative of constitutive activation of the Wnt signaling
pathway. The severity of the Lin28bLo/Let7IEC-KO phenotype was substantially more dramatic
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than in Vil-Lin28bLo or Vil-Lin28bMed mice (18). Vil-Lin28bMed mice express higher levels of
Lin28b, have partially depleted Let-7 miRNAs and develop adenocarcinomas of the small intes-
tine as do Lin28bLo/Let7IEC-KOmice but do not exhibit a phenotype as severe as Lin28bLo/
Let7IEC-KO mice (18).
Identification of Relevant Let-7 Target mRNAs in the Intestinal
Epithelium and Tumors
Let-7 targets were examined in small intestine crypts from Vil-Lin28b and Lin28bLo/Let7IEC-KO
mice. RNA microarray expression analysis was previously performed on Vil-Lin28bMed total
small intestine epithelia and we verified elevation of Hmga1,Hmga2, Igf2bp1, Igf2bp2, E2f5,
Acvr1c, Nr6a1, Hif3a, Arid3a, Plagl2, Trim6, Ddx19a, andMycn (Fig 2A and [18]). We also
observed significant elevation of mRNAs for these Let-7 targets in crypts from small intestine
epithelia from Lin28bLo/Let7IEC-KO (Fig 2B). Expression of all Let-7 targets also correlated sig-
nificantly between Lin28bLo/Let7IEC-KO and Vil-Lin28bMed intestine crypts, withHmga2,
Igf2bp2,Hif3a, Arid3a, and E2f5 being the most highly induced targets in both models (Fig
2C). All targets contained conserved Let-7 sites in the 3’UTR or coding sequence, except for
Trim6, for which only the mouse mRNA possesses Let-7 sites (Fig 2D). In addition to our
Fig 1. Comprehensive depletion of all Let-7 miRNAs leads to the development of intestinal adenocarcinomas. A) Schematic of the intestine-specific
deletion of theMirlet7c-2/Mirlet7b floxed locus via Villin-Cre and expression of Lin28b with a Villin-Lin28b-ires-tdTomato transgene, which repress all 8 of
the Let-7 clusters. Let-7 miRNA genes are shown as black hairpins while non-let-7 miRNA genes are depicted as gray hairpins. B) Kaplan-Meier plot showing
survival over 10 months. C) Representative small intestine from a Lin28bLo/Let7IEC-KO mouse containing two tumors, T1 and T2 (box outline with yellow
dotted lines). D) Large tumor from (C) dissected with luminal side facing outward. E) H&E stained paraffin section of adenocarcinoma from a Lin28bLo/
Let7IEC-KO mouse. F) Representative section of adenocarcinoma from a Lin28bLo/Let7IEC-KO mouse immunostained for β-catenin, showing a nuclear pattern
of localization. Scale bars in (E) and (F) = 100 μm.
doi:10.1371/journal.pgen.1005408.g001
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Fig 2. Quantification of Let-7 target mRNA levels in intestinal epithelium crypts. A) Expression of Let-7
target mRNA levels in small intestine crypts isolated fromwild-type (WT) and Vil-Lin28bMedmice. B)
Expression of Let-7 target mRNA levels in small intestine (jejunum) crypts isolated fromwild-type (WT), Vil-
Lin28bLo, Let7IEC-KO, Lin28bLo/Let7+/-, and Lin28bLo/Let7IEC-KO mice. C) Comparison of Let-7 target mRNA
changes in small intestine crypts from Vil-Lin28bMedmice vs. Lin28bLo/Let7IEC-KO mice reveals similar
expression changes in each model of Let-7 depletion, with significant correlation (Pearson correlation
shown). Expression analysis was performed by Q-RT-PCR, normalized to Hprt and Actb, with n = 3 mice for
each genotype at 12 weeks of age with error bars representing +/–the S.E.M. D) Identification of conserved
Let-7 target genes in ten of eleven Let-7 target genes based upon TargetScan.org prediction. Student’s two-
tailed T-tests were performed to determine significance with * p-value < 0.05, ** p-value < 0.01, and *** p-
value < 0.001, relative to WT small intestine. One-way ANOVA standard weighted-means analysis was also
performed in B, with p-values < 0.05 indicated above each gene. Tukey's HSD (honest significant difference)
post-test was also performed in B, with samples p < 0.05 (red asterisk) and p < 0.01 (†) indicated, relative to
mean of WT small intestine.
doi:10.1371/journal.pgen.1005408.g002
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findings for HMGA2, IGF2BP1, and IGF2BP2, there is experimental evidence that HMGA1,
E2F5, and ARID3A are also direct targets of Let-7 [6,31,32].
To gain insight into the association of several Let-7 targets with tumorigenesis in vivo, we
examined Hmga1, Hmga2, Arid3a, and Hif3a protein expression by immunostaining adeno-
mas and adenocarcinomas, as well as adjacent normal tissue, from Lin28bLo/Let7IEC-KO mice.
These targets exhibited little or modest up-regulation in normal small intestine epithelia of
Lin28bLo/Let7IEC-KO mice, but dramatic increases in tumors (Fig 3A–3J and S3A–S3H Fig).
Pathological assessment of the staining pattern revealed that Hmga1 and Hmga2 staining was
most intense in areas of invasive adenocarcinoma (Fig 3G, 3H and 3I).
We next examined Let-7 targets that might mediate programs of tumorigenesis in Lin28bLo/
Let7IEC-KO mice in the context of tumors and cellular transformation. To model intestinal epi-
thelial carcinogenesis we developed a 3-D culture model to examine only the epithelium and to
select transformed tumor cells (Fig 4A). Enteroids derived from CRC tumors appear to faith-
fully recapitulate the major expression signatures of un-manipulated whole tumors [33]. To
pursue this, we micro-dissected and dissociated adenocarcinomas from Lin28bLo/Let7IEC-KO
mice and cultured “tumoroids” from these lesions in medium supplemented with EGF, Nog-
gin, and Rspo1, as described previously for enteroid culture [34]. These tumoroid/enteroids
(T/E) resembled normal small intestine enteroids (Fig 4B) and are likely a mixture of different
cell types, but upon withdrawal of Noggin and Rspo1, a small population of growth-factor
independent cells expanded into tumoroid cysts (TC) (Fig 4C), which likely possess cell-auton-
omous activation of Wnt signaling and Noggin-independent resistance to BMP signaling.
Quantification by Taqman RT-PCR confirmed that Let-7 miRNAs are severely repressed in
tumoroid/enteroids and transformed tumoroid cysts (Fig 4D). Tumors and tumoroids, but not
normal tissue from Lin28bLo/Let7IEC-KO mice, also exhibited up-regulation of Wnt target genes
Axin2, CD44, and cMyc (Fig 4E), suggesting spontaneous and constitutive activation of Wnt
signaling. Analysis of Let-7 target mRNAs revealed two basic patterns of expression, with one
group displaying expression highest in intact tumors or tumoroids/enteroids (Fig 4F). The
other group displayed increasing or plateauing expression, with higher levels in tumoroid/
enteroids or tumoroid cysts (Fig 4G). In this latter group we find known and suspected onco-
genes, such asHmga1, Hmga2, Igf2bp1, Igf2bp2, andMycn. As Hmga2 appeared to exhibit pro-
nounced up-regulation (>200-fold) in the tumoroid/enteroid and tumoroid cyst populations,
and increased staining in invasive areas of adenocarcinomas (Fig 3H), we evaluated Hmga2 co-
localization with nuclear β-catenin in mouse tumors, to assay potential coincident activation of
canonical Wnt signaling with nuclear Hmga2. Immunostaining in both adenomas and adeno-
carcinomas from Lin28bLo/Let7IEC-KOmice revealed frequent and intense co-staining of
Hmga2 with nuclear β-catenin (Fig 4H–4K). This pattern of co-staining was not observed for
Hmga1, Arid3a, or Hif3a.
Let-7 Down-Regulation and HMGA2 Up-Regulation Are Associated with
a Stem Cell Signature in Intestinal Cancers in Humans and Lin28bLo/
Let7IEC-KO Mice
To extrapolate relevance to human CRC from these mouse models, we examined expression
data from human samples from The Cancer Genome Atlas (TCGA) [35] by querying for
expression of Let-7 target mRNAs, with a focus on targets that exhibited significant up-regula-
tion in either Vil-Lin28bMed or Lin28bLo/Let7IEC-KO mouse models (namely, ARID3A, PLAGL2,
HMGA1,HMGA2,MYCN, IGF2BP1, IGF2BP2, and E2F5). We examined a cohort of 416 CRC
patients from a TCGA dataset and found that all transcripts except HIF3AmRNA were signifi-
cantly elevated in cancer tissue compared to expression levels in normal tissues (Fig 5A).
Let-7, HMGA2, and Colorectal Cancer
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Fig 3. Hmga1 and Hmga2 proteins are increased in invasive areas of adenocarcinomas.
Immunohistochemical staining for Hmga2 (A-C, G, H) and Hmga2 (D-F, I, J), in sections fromWT small
intestine (S.I.) (A, D), Lin28bLo/Let7IEC-KO S.I. (B, E), Lin28bLo/Let7IEC-KO adenoma (C, F), and Lin28bLo/
Let7IEC-KO adenocarcinoma (AdenoCA) (G-J). An enlargement of a region containing invasive
HMGA1-positive tumor cells from G (dotted yellow box) is pictured in H, while a region containing invasive
HMGA2-positive tumor cells from I is likewise displayed in J. Pictures in A-F, H, and J are at same
magnification (200x), with scale bar = 100 μm, while pictures in G and I are both at 40x, with scale
bar = 250 μm.
doi:10.1371/journal.pgen.1005408.g003
Let-7, HMGA2, and Colorectal Cancer
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Fig 4. Identification of Let-7 targets up-regulated specifically in transformed cells from intestinal adenocarcinomas. A) Schematic of experimental
procedure where tumors were micro-dissected from the small intestine (S.I.) of Lin28bLo/Let7IEC-KO mice and cultured as epithelial tumoroid/enteroids (T/E),
grown in ENRmedium, and tumoroid cysts (TC), grown in medium lacking Noggin and Rspo1. B) Typical tumoroid grown in ENRmedium. C) Tumoroid cysts
grown in basal medium containing EGF. D) Let-7 miRNAs are repressed consistently in tumoroid/enteroids (TE) and tumoroid cysts (TC). E) Wnt (Tcf4/β-
catenin) target genes Axin2, CD44 and cMyc mRNAs were up-regulated in tumors, T/E, and TC. F) Transcripts with highest expression in tumor or tumoroid,
but tend to be down-regulated in tumoroid cysts. G) Transcripts that maintain high expression and/or are increased in tumoroid cysts. Note logarithmic scale
where Hmga2mRNA is induced approximately 200-fold in TC compared to wild-type S.I. Immunostaining in Lin28bLo/Let7IEC-KO adenomas (H, I) and
adenocarcinomas (J, K) revealed that nuclear β-catenin (H, J) and Hmga2 (I, K) are often co-expressed at high levels. Expression analysis was performed by
Let-7, HMGA2, and Colorectal Cancer
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IGF2BP1 expression in primary tumors was also associated with an increased likelihood of hav-
ing nodal metastases (Fig 5A). Levels of HMGA1, HMGA2, PLAGL2, IGF2BP2, E2F5, and
ARID3A transcripts were also inversely proportional to levels of Let-7 miRNA by examination
of a cohort of 199 CRC patients from the TCGA Pan-Cancer analysis project [20] (Fig 5B–5E
and S1D–S1I Fig). Since Let-7a and Let-7b appear to be the most highly expressed Let-7 miR-
NAs in normal colonic epithelium, and are significantly depleted in CRC specimens [20,30]
(S1A, S1B and S1C Fig), we examined these miRNAs in a subset of colon cancer specimens.
We also compared their expression with the crypt-base-columnar (CBC) stem cell markers
EPHB2, ASCL2, and LGR5, which are markers of stem cells in human intestine/colon and
CRC, and are associated with aggressive CRC [36]. We found that Let-7a and Let-7b were sig-
nificantly down-regulated in CRC specimens, while stem cell markers were significantly up-
regulated (Fig 5F and 5G). Let-7a and Let-7b levels were also correlated tightly, suggesting co-
regulation (Fig 5H), and were also inversely proportional to the expression of the stem cell
markers EPHB2 and LGR5 (Fig 5I). This suggests provocatively that Let-7a and Let-7b deple-
tion may contribute to a stem cell phenotype in the intestine, and perhaps CRC.
To further examine this relationship we evaluated small intestine stem cell markers in wild-
type intestine, Lin28bLo/Let7IEC-KO intestine, and in tumors from Lin28bLo/Let7IEC-KOmice. In
normal adjacent tissue we observed a trend toward increased expression of multiple stem cell
markers in Lin28bLo/Let7IEC-KO small intestine (Fig 5J). In contrast, tumors from Lin28bLo/
Let7IEC-KOmice exhibited a pronounced up-regulation of all stem cell markers assayed, including
Bmi1, Lrig1, Olfm4, Ascl2, Prom1, Lgr5,Msi1, and Sox9 (Fig 5J), perhaps suggesting an expansion
of CBC and +4 stem cell-like compartments. While Let-7a and Let-7b depletion and increased
expression of stem cell markers may appear to be a general feature of colon cancer, our discovery
of a relationship between expression of Let-7 and stem cell markers suggests a functional connec-
tion. To examine a possible relationship between Let-7 target mRNAs and stem cell markers, we
evaluated co-expression in mouse samples (from Fig 5I) and found that Hmga1 and Hmga2 had
very high correlation with all of the markers we examined (Fig 5K). Likewise, in human CRC
samples the expression of HMGA2 directly correlates with LGR5 levels (Fig 5L).
HMGA1 or HMGA2 Expression Is Associated with Aggressive CRC in
Patients
In order to explore any disease relevance connecting HMGA1 and HMGA2 expression and
tumor phenotype, we stained CRC tumor tissue arrays for these proteins and evaluated expres-
sion in relationship to various parameters including tumor stage, histopathologic characteris-
tics, and disease outcomes. High-level HMGA1 expression predicted poor survival for patients
with stage II tumors (S2A Fig). HMGA1 staining was also more intense in stage II tumors (S2C
and S2D Fig) and in tumors with perineural invasion (S2E and S2F Fig). Interestingly, expres-
sion data from TCGAmRNA-seq studies [37] indicated that high-level expression of HMGA2
correlates inversely with survival (S2B Fig). In tissue arrays HMGA2 expression was greater in
non-mucinous tumors (S2G and S2H Fig) and in stage III tumors (S2I and S2J Fig). In aggre-
gate, these data suggest that HMGA1 and HMGA2 are expressed in non-overlapping tumor
types, but are both associated with more aggressive phenotypes, and perhaps reduced patient
survival.
Q-RT-PCR, normalized to Hprt and Actb, with n = 3–4 for each tissue/organoid with error bars representing +/–the S.E.M. Student’s two-tailed T-tests were
performed to determine significance with * p-value < 0.05, ** p-value < 0.01, and *** p-value < 0.001, relative to wild-type small intestine. One-way ANOVA
standard weighted-means analysis was also performed in D-G, with p-values < 0.05 indicated above each gene. Tukey's HSD (honest significant difference)
post-test was also performed in D-G, with samples p < 0.05 (red asterisk) and p < 0.01 (†) indicated, relative to mean of WT small intestine (jej.).
doi:10.1371/journal.pgen.1005408.g004
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Fig 5. Let-7 and HMGA2 are associated with a stem cell signature in intestinal adenocarcinomas. A) Heat map of TCGAmRNA-seq colon and rectal
adenocarcinoma dataset from UCSC Cancer Genome Browser (genome-cancer.ucsc.edu) comparing expression of Let-7 target mRNAs in normal tissue (N.
T.) vs. cancer. Significant up-regulation (red) or down-regulation (green) is indicated below heatmap in plots of the-log(p-value) of Benjamini-Hochberg-
corrected T-tests on the y-axis. T-test results are shown for expression in tumors vs. N.T. and in tumors associated with at least one lymph node metastases
vs. tumors with no associated lymph node metastases. Inverse relationships for Let-7 and target mRNAs could be discerned by plotting miRNA-seq data
against mRNA-seq data for Let-7c vs. HMGA2 (B), Let-7a vs. PLAGL2 (C), Let-7a vs.HMGA2 (D), and Let-7a vs. IGF2BP2 (E). F) Taqman QPCR for mature
Let-7a and Let-7b miRNAs in a cohort of colon adenocarcinomas (N = 20) indicates that Let-7a and Let-7b are down-regulated. G) Intestinal epithelial stem
cell markers EPHB2, ASCL2, and LGR5 are significantly up-regulated in colon cancer vs. normal adjacent tissues. H) Mature Let-7a and Let-7b levels are
tightly correlated in these tissue specimens. I) Let-7a and Let-7b levels are inversely proportional to mRNA levels of stem cell markers EPHB2 and LGR5,
suggesting that Let-7 may repress a stem cell signature. J) Expression of stem cell markers is dramatically up-regulated in Lin28bLo/Let7IEC-KO tumors,
relative to WT jejunum, with a trend for up-regulation in Lin28bLo/Let7IEC-KO jejunum, relative to WT. K) Comparison of stem cell marker expression and Let-7
target mRNA expression levels in WT jejunum, Lin28bLo/Let7IEC-KO jejunum, and Lin28bLo/Let7IEC-KO tumors by linear regression yielded Pearson
correlation coefficients, with Arid3a, Hmga1, andHmga2 correlating very highly with expression of stem cell markers. L) HMGA2 and LGR5 expression from
the TCGAmRNA-seq colon and rectal adenocarcinoma dataset exhibit significant positive correlation. Expression analysis (F-K) was performed by QPCR,
normalized to Hprt and Actb, with n = 3–4 for each mouse genotype with error bars representing +/–the S.E.M. Human QPCRwas normalized to PPIA and
B2M, with error bars representing +/–the S.E.M. Student’s two-tailed T-tests were performed to determine significance with * p-value < 0.05, ** p-
value < 0.01, and *** p-value < 0.001.
doi:10.1371/journal.pgen.1005408.g005
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HMGA2 Drives a Stem Cell Phenotype and Is Required for Lin28b-
Mediated Tumorigenesis
We next pursued 3-D culture and manipulation of intestinal organoids (enteroids) to explore
the relationship between Let-7 targets and a stem cell phenotype. This method has facilitated
the examination of stem cell phenotypes in the intestinal epithelium in multiple studies
[34,38–44]. For these experiments we derived enteroids from Vil-Lin28bMed mice [18]. We
have previously shown that crypt hyperplasia and Hmga2 expression is dependent on Let-7
depletion in crypts from Vil-Lin28bMed mice [18]. Enteroids derived from Vil-Lin28bMed mice
exhibited enhanced colony forming potential of single cells (Fig 6A, 6B and 6C). This is
unlikely to be a feature secondary to enhanced stem cell potential conferred by increased asso-
ciation with Paneth cells, as described previously [34], since this cell type is severely depleted
following Let-7 repression [18]. To assay exogenous expression of Let-7 targets in enteroids, we
used a lentivirus vector for transduction of wild-type mouse small intestine enteroids (Fig 6D–
6G). This vector system yields low (Fig 6J) or high-level (Fig 6K) expression, in a doxycycline-
dependent manner. We generated stable enteroid lines for inducible expression of mouse
Hmga2, Igf2bp2, E2F5, Arid3a, or Hif3a and assayed colony forming potential and EdU incor-
poration. We focused onHmga2, rather thanHmga1, as it is consistently up-regulated in non-
malignant intestinal tissue from Vil-Lin28bMed and Lin28bLo/Let7IEC-KO and thus appears
highly dependent on Let-7 [18]. For colony formation, only Hmga2 over-expression (O/E)
exhibited a significant effect, with enhanced formation of new enteroids from singly plated
cells (Fig 6L, 6M and 6N), whereas Igf2bp2, E2F5, Arid3a, and Hif3a had no apparent effect
(Fig 6L and S4A Fig). Expression ofHmga2, Arid3a,Hif3a, or Igf2bp2 via lentiviral vectors did
not induce any change in stem cell markers (S4B–S4K Fig). To determine if Hmga2 was neces-
sary for the enhanced colony formation in Vil-Lin28b enteroids, we crossed Vil-Lin28bMed
mice onto background in which one allele ofHmga2 is inactivated specifically in the intestine
(Vil-Cre+/Hmga2CK/+) [45], and generated enteroids. We used Vil-Lin28bMed mice because
their phenotype appears Let-7-dependent [18] and for simpler breeding. Effects on colony for-
mation by Lin28b were greatly blunted by inactivation of a single Hmga2 allele (Fig 6O).
Hmga2 could also trigger increased EdU incorporation in intestinal enteroids, whereas Hif3a
repressed it, suggesting opposing effects ofHmga2 and Hif3a on cellular proliferation (Fig 6P
and 6Q). Lentiviral-mediated expression and manipulation of the Hmga2 conditional allele
were restricted to coding sequence only [45]. Perhaps consistent with its association with a
stem cell phenotype, HMGA2 is also frequently co-expressed with the stem cell markersMSI1
and LGR5 in human CRC, and notably, more frequently than any of the other Let-7 targets
evaluated here in this study (Fig 5L and S2 Table). Lastly, to evaluate the role of Hmga2 in
intestinal tumorigenesis in the context of Let-7 depletion we examined tumor burden in Vil-
Lin28bMed and Vil-Lin28bMed/Hmga2+/IEC-KO mice. As mentioned earlier, Vil-Lin28bMed mice
have a lower penetrance of intestinal tumorigenesis compared to Lin28bLo/Let7IEC-KO mice,
with about 50% of animals developing tumors by 9 months of age (S3 Table). Inactivation of
one allele of Hmga2 in the intestinal epithelium significantly reduced disease penetrance and
tumor burden in Vil-Lin28bMed/Hmga2+/IEC-KO mice (S3 Table).
Discussion
We have achieved comprehensive depletion of all Let-7 miRNAs in the intestinal epithelium and
demonstrated the critical nature of their cumulative tumor-suppressive properties. These effects
appear to be due to Let-7, although LIN28B can bind mRNAs and modulate protein levels of tar-
gets in the intestinal epithelium [18]. However, this appears unlikely in Lin28bLo/Let7IEC-KOmice
since LIN28B did not have any effect on RNA or protein levels of targets in the context of low-
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level expression in Vil-Lin28bLomice [18]. While tumors from Lin28bLo/Let7IEC-KOmice appear
to be more advanced than those from Vil-Lin28bMedmice [18], surprisingly there is not a signifi-
cant difference in tumor multiplicity. Nascent tumorigenesis beginning with aberrant crypt foci
and/or microadenomas may occur spontaneously in our mouse model of Let-7 depletion, likely
due to sporadic deregulation ofWnt signaling or potential spontaneous loss of other tumor sup-
pressive mechanisms. Therefore, Let-7 may not have the “gatekeeper” function that is character-
istic of tumor suppressors such as APC. Despite this, there is a link between LIN28B expression
Fig 6. Hmga2mediates Lin28b effects on stem cell colony formation and enteroid proliferation. Colony formation assay of small intestine enteroids
from wild-type (WT) mice (A) and Vil-Lin28bMedmice (B). Two wells of a 24-well plate are pictured. C) Quantification of colony forming assay of WTmice and
Vil-Lin28bMed mice. D) Schematic of lentiviral vector-mediated transduction of enteroids with a “tet-on” doxycycline (dox)-inducible vector. Inducible
expression of a turbo RFP reporter in the unmodified pTRIPz vector is readily observed in enteroids (H) vs. untreated cells (G). Phase contrast images of
untreated and doxycycline treated enteroids are pictured in (E) and (F), respectively. Immunostaining for Hmga2 in sectioned enteroids from pTRIPz-
transduced (I), pTRIPz-Hmga2-transduced (J), and pTRIPz-Hmga2-transduced plus doxycycline (K). L) Comparison of colony forming potential of cells from
dissociated enteroids transduced with pTRIPz (empty), Arid3a, Hif3a, or Hmga2 vectors. Phase contrast images of colony formation assays from enteroids
transduced with pTRIPz (empty) (M) or Hmga2 (N) vectors. O) Colony forming assays of non-transgenic mice (NTG) or Vil-Lin28bMedmice with and without
inactivation of one conditional Hmga2 allele using Vil-Cre. EdU incorporation of enteroids, as assayed by flow cytometry, transduced with pTRIPz-Hmga2 (P)
or pTRIPz-Hif3a (Q) vectors. Cultures were treated with 100 ng/ml doxycycline in all experiments except in (F) and (H), which were treated with 500 ng/ml
doxycycline. All experiments were performed at least in triplicate. Student’s two-tailed T-tests were performed to determine significance with * p-value < 0.05,
** p-value < 0.01, and *** p-value < 0.001, relative to pTRIPz vector controls, unless noted otherwise.
doi:10.1371/journal.pgen.1005408.g006
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in human colon cancer samples and aggressive disease in early stages, which may reflect a role
for LIN28B in early neoplastic growth [15]. Supporting this hypothesis is the documentation that
LIN28 proteins and Let-7 miRNAs do indeed affect proliferation, migration, and invasion in cell
culture models and xenografts of various malignancies [16,17,46–49]. However, the differences
between Let-7 target mRNAs in each of these models can be quite disparate; e.g. KRAS has a
larger effect on tumorigenesis than doesHMGA2 in a non-small cell lung cancer model [49],
whereasHMGA2 appears to have a much larger role in other cancer models [28,50–53], likely as
a modifier of chromatin structure and gene expression [54–57].
As documented in developmental programs in C. elegans and in human cancers, Let-7 miR-
NAs repress a stem cell phenotype and tumor-initiating phenotype [3], an association we
observe here as well. The connection between HMGA2 and a stem cell phenotype in the intesti-
nal epithelium is also intriguing. HMGA2 promotes somatic stem cell specification, with such
roles in neural stem cells and hematopoietic stem cells [25–27]. In some contexts, HMGA2 can
enhance Wnt signaling, a known driver of the crypt-base-columnar (CBC) intestinal epithelial
stem cell phenotype [34,58,59]. This was observed in a mouse model of prostatic intraepithelial
neoplasia, where overexpression of Hmga2 in cancer-associated fibroblasts enhances expres-
sion of the Wnt ligandsWnt2,Wnt4, andWnt9b, concomitant with enhanced Wnt signaling
and nuclear β-catenin in adjacent neoplastic epithelium [60]. Wnt signaling is required for the
enhanced prostatic intraepithelial tumorigenesis induced by Hmga2 in this model [60]. How-
ever, we do not observe any effects onWnt target genes or β-catenin localization in non-malig-
nant Lin28bLo/Let7IEC-KO intestine tissue, suggesting that Wnt deregulation may be an
independent event. A recent study that largely replicated our earlier work found that tumors
triggered by transgenic LIN28B expression in the mouse small intestine frequently have muta-
tions in Ctnnb1 (β-catenin), but not Apc [61]. Although the level of induced LIN28B expression
in this study is likely much higher than in Lin28bLo/Let7IEC-KO mice, and therefore different,
we suspect that derangements of the Wnt pathway, e.g. in Ctnnb1, are also occurring in tumors
in Lin28bLo/Let7IEC-KO mice, as evidenced by frequent nuclear β-catenin.
Alternatively, the co-localization of nuclear β-catenin with intense Hmga2 staining in
mouse tumors (Fig 6K–6N) could reflect Wnt signaling enhancement of Hmga2 expression, a
phenomenon observed in triple-negative breast cancer, a subtype that also tends to express
high LIN28B levels [9,62]. Curiously, in our genetic manipulations of enteroids, exogenous
Hmga2 does not affect expression of stem cell markers (such as those assayed in Fig 6I) in
transduced intestinal enteroids (S4 Fig). Alternatively, increased Hmga2 expression may
enhance survival of stem cells or facilitate the recruitment of a facultative population (such as
the quiescent “+4” secretory progenitor stem cell) and entry into the cell cycle. Or, Hmga2 may
synergize with deregulated Wnt signaling in the promotion of a stem cell phenotype, which
could account for the dramatic up-regulation of stem cell markers we see in tumors from
Lin28bLo/Let7IEC-KO mice. Others have also reported that HMGA2 expression is predictive of
aggressive disease and poor outcomes in CRC [63], as similarly found in other cancers [50].
While HMGA2 is playing a key role, it is likely that the effects of Let-7 on an intestinal stem
cell phenotype and epithelial tumorigenesis are dependent on the collective and/or cooperative
role of multiple Let-7 targets. Not uncommonly, additive roles of target genes are uncovered in
the genetic dissection of a single pathway, such as that seen for PDGF-receptor signaling and
the collective biological contribution of multiple target genes dependent on Pdgfra and Pdgfrb
[64]. However, it is challenging to dissect the combinatorial relationships among a dozen can-
didate targets, especially in mouse models. An oncogenic function of HMGA1 and IGF2BP1
has been reported in other cancers, including colon cancer, with evidence that both factors
enhance tumorigenesis [65,66]. Dissecting the interaction and possible cooperation of Let-7
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target mRNAs is critical for designing strategies to ameliorate the loss of Let-7 in human can-
cers via combinatorial targeted therapies against multiple oncogenes.
Materials and Methods
Ethics Statement
Mouse studies were approved by the University of Pennsylvania Animal Care and Use Com-
mittee, protocol #802791.
Mouse Models
Vil-Lin28bLo, Vil-Lin28bMed, and Let7IEC-KO mice were described previously [18], and were
maintained via backcrosses to C57BL/6J. Vil-Lin28bMedmice express Lin28b protein approxi-
mately 2-fold higher than Vil-Lin28bLomice. To obtain Lin28bLo/Let7IEC-KOmice, VilCre+/
Let7lox/loxmice were mated with Vil-Lin28bLo/Let7lox/loxmice to get Vil-Lin28bLo/VilCre+/Let7lox/
lox, and all other possible genotypes. Let7lox/loxmice were considered wild-type and possess all
Let-7 miRNAs at levels insignificantly different from wild-type mice [18]. Conditional null
Hmga2Ckmice were described previously [45]. Mice were sacrificed at 12 weeks or between 10
and 14months of age for dissection, isolation of tissues for histology and immunohistochemistry,
and isolation of intestinal epithelia. Pathological criteria for mouse intestinal tumors were used
as previously defined [67]. Intestinal adenomas are exophytic growths without evidence of inva-
sion characterized by enlarged variably hyperchromatic nuclei with altered glandular architec-
ture, including enlarged crypts and budding, irregular glands. For purposes of defining an
adenocarcinoma, tumor invasion through the lamina propria into the muscularis mucosa and
eventually beyond must clearly be seen.
Quantitative RT-PCR
For mRNA expression analysis of mouse tissue, whole jejunum, total intestinal epithelium, or
crypt epithelium was isolated for homogenization in Trizol (Life Technologies). Total epithe-
lium or crypts were isolated as described previously [18]. Total RNA (2–5 μg) was used for
cDNA synthesis with oligo dT primers and Superscript III RT (Life Technologies) according to
the manufacturer instructions. QPCR was performed using Taqman technology or Sybr green
using the TaqMan Fast Universal PCR Master Mix (2X), no AmpErase UNG (Life Technolo-
gies) or the Power SYBR Green PCRMaster Mix (Life Technologies). Expression levels of que-
ried mRNAs were normalized to β-actin (Actb) andHprt or GapdhmRNA levels. Let-7
miRNAs were quantified using Taqman Q-RT-PCR kits (Life Technologies), according to the
manufacturers instructions and normalized to U6 and SNO135 small RNA levels. Primers and
Taqman probes are listed in S3 Table.
Human colon cancer tumor specimens, along with adjacent matched non-malignant tissue,
were obtained from the Siteman Cancer Center Tissue Procurement Core as fresh frozen sec-
tions. Twenty samples (11 pairs) were obtained and total RNA was isolated following homoge-
nization with Trizol (Life Technologies). For qualitative evaluation of RNA integrity 2 μg of
total RNA was electrophoresed on a 1% agarose gel. For evaluation of mRNAs, 1 μg of total
RNA was used for reverse transcriptase using the iScript reverse transcriptase kit (BioRad),
while miRNAs were quantified using Taqman Q-RT-PCR kits (Life Technologies), according
to the manufacturers instructions. Levels of mRNAs were assayed using standard primer pairs
and SsoFast EvaGreen Supermix (Biorad) and normalized to cyclophilin-A (PPIA) and β-2
microglobulin (B2M). Let-7a and Let-7b miRNAs were normalized to U6 and RNU6B RNAs.
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Enteroid/Tumoroid Culture
Crypts were isolated as described previously [18] and cultured in EGF, Noggin, and Rspo1
(ENR) medium [34]. Before plating, crypts were counted and re-suspended in a mixture of
80%Matrigel (BD Biosciences) and 20% ENR at a concentration of 20 crypts per μl. For initial
plating and the first three days of culture, crypts were grown in the presence of 10 μMRho
kinase (ROCK) inhibitor (Y27632). Medium was then changed every 3 days with fresh ENR
medium. For lentiviral transduction the pTRIPz vector was modified for expression of mouse
Hmga2 (NM_010441.2), E2f5 (NM_007892.2), Igf2bp2 (NM_183029.2), Arid3a
(NM_001288625.1) or Hif3a (NM_016868.3) by cloning the open reading frames from these
cDNAs between the AgeI andMluI sites within pTRIPz. Enteroids were transduced with lenti-
viral particles as described previously and selected with 2 μg/ml puromycin [68].
Colony Formation Assays
Enteroids were mechanically dissociated by pipetting up and down in 4 ml basal medium and
centrifuged at 100 x g for 2 min. Enteroids were then re-suspended in 0.5 ml TrypLE Express
(Life Technologies) containing 250 U/ml DNase I (1:200) and 10 μMROCK inhibitor. Enter-
oids were incubated 5 minutes at 37°C with periodic vortexing every 60 sec. To this we added
one volume basal medium with 5% FBS (with DNase and ROCKi) and spun 5 min at 200 x g.
Cells were re-suspended in 0.5 ml pre-warmed basal medium with 50 U/ml DNase I and
10 μMROCK inhibitor and incubated 5 minutes at room temperature with periodic vortexing.
Single cells were then plated in triplicate at a concentration of 2500 cells per cm2 in 80% Matri-
gel, 20% ENR, and over-layed with ENR medium plus 10 μMROCK inhibitor. Colonies of
growing, budding enteroids were counted 5–7 days after plating.
For assaying 5-ethynyl-2´-deoxyuridine (EdU) incorporation, enteroids were given fresh
new medium containing 10 μM EdU and incubated for 2 hours. Enteroids were then isolated as
performed above to obtain a single cell suspension, then fixed for Click-iT labeling and flow
cytometry using the Click-iT Plus EdU Alexa Fluor 488 Flow Cytometry Assay Kit (Life Tech-
nologies). Fixation and labeling was carried out according to the manufacturer instructions.
Tumoroid Cultures
Mouse intestinal tumors were isolated for culture by micro-dissecting tumor tissue away from
normal adjacent mucosa using a dissecting microscope. Two pieces of tumor were processed
for RNA isolation and histology and immunohistochemistry while a third piece was dissociated
for culture. For tumoroid culture, tumors were placed into HBSS containing 10 mM EDTA, 1
mMN-acetyl-cysteine (NAC), and 10 μMROCK inhibitor (Y27632) and incubated at 37°C
with periodic vortexing for approximately 5 to 10 minutes until the epithelium began to detach.
Isolated epithelium was then washed three times with sterile basal medium and plated in cul-
ture as done above for enteroids in ENR medium. After 1–2 weeks of continuous culture and
1–2 passages, tumoroids were placed into medium lacking Noggin and Rspo1. While most
enteroids died, small rare surviving colonies could be observed after 3–5 days of culture. These
tumoroid cysts were maintained in medium lacking Noggin and Rspo1.
Immunohistochemistry (IHC)
Paraffin-embedded enteroids, intestinal tissue, and tissue microarrays were incubated at 56°C
prior to de-waxing and rehydration. Antigens were retrieved by boiling sections in 10 mM cit-
ric acid, pH 6.0, for 2 hrs. Samples were blocked in 1% BSA, 0.3% Triton-X-100, and 10% nor-
mal goat serum for 1 hr. Endogenous peroxidases were quenched in 3% hydrogen peroxide for
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5 minutes. In conjunction with biotin-conjugated secondary antibodies (Jackson ImmunoRe-
search, diluted 1:200) stains were developed with the VECTASTAIN Elite ABC Kit (Vector
Laboratories, cat# PK-6100) and the DAB Peroxidase (HRP) Substrate Kit (Vector Laborato-
ries, cat# SK-4100). Tissues were dehydrated and cover-slipped with Cytoseal (Thermo Scien-
tific, cat# 8310–4). Primary antibodies used for IHC were anti-ARID3A (1:100, ProteinTech,
Chicago IL, cat# 14068-1-AP), anti-β-catenin [D10A8] XP Rabbit mAb (1:100, Cell Signaling,
Danvers MA, cat# 8480), rabbit anti-HIF3A antibody (1:200, Sigma-Aldrich, St. Louis MO,
cat# SAB2900410), anti-HMGA1 antibody [EPR7839] (1:250, Abcam, Cambridge MA, cat#
ab129153), and anti-HMGA2 [D1A7] rabbit mAb (1:400, Cell Signaling, Danvers MA, cat#
8179).
Human Cancer Dataset Analyses
We examined gene expression in CRC specimens from a cohort of 416 CRC patients from a
TCGA dataset using the cancer genome browser at UCSC (https://genome-cancer.ucsc.edu/proj/
site/hgHeatmap/) (Cline MS 2013; Lopez-Bigas N 2013; GoldmanM 2012; Sanborn JZ 2011;
Vaske CJ 2010; Zhu J 2009). For examination of Let-7 miRNA expression and expression relative
to candidate target genes we examined a cohort of 199 CRC patients from the TCGA Pan-Cancer
analysis project visualized using the starbase miRNA CLIP-seq portal (http://starbase.sysu.edu.
cn/) (Li JH et al., Nucleic Acids Res. 2014; Yang JH et al., Nucleic Acids Res. 2011).
Supporting Information
S1 Fig. Let-7 miRNAs and Let-7 Target anti-correlation in CRC TCGA datasets. A-C) Box-
and-whisker plots for Let-7a, Let-7b, and Let-7c, demonstrating significant down-regulation in
colon and rectal cancer (CRC) miRNA-seq dataset. Box plot whiskers represent 1.5x the inter-
quartile range (IQR) above the third quartile or below the first quartile. D-I) Scatter plots of
Let-7 miRNA expression vs. target mRNA levels from CRC miRNA-seq and mRNA-seq data-
sets. Pearson correlation coefficients and p-values are indicated on each graph.
(TIF)
S2 Fig. HMGA1 and HMGA2 tumor tissue array analysis. A) Kaplan-Meier curve depicting
survival in patients with high HMGA1 staining scores vs. low staining scores. B) Kaplan-Meier
curve depicting survival in patients with high HMGA2 levels from RNA-seq data [37]. High
levels are defined as expression at least one standard deviation above the mean. C) Contingency
table of HMGA1 staining intensity (high or low) vs. tumor stage (II or III). D) Chi-Square test
for data in (C) revealing a significant difference in staining intensity, with more stage II tumors
exhibiting higher levels of HMGA1 staining. E) Contingency table of HMGA1 staining inten-
sity (high or low) vs. tumor perineural invasion. F) Chi-Square test for data in (E) revealing a
significant difference in staining intensity, with more tumors with perineural invasion exhibit-
ing higher levels of HMGA1 staining. G) Contingency table of HMGA2 staining intensity
(high or low) vs. tumor mucinous phenotype. H) Chi-Square test for data in (G) revealing a
significant difference in staining intensity, with non-mucinous tumors exhibiting higher levels
of HMGA2 staining. I) Contingency table of HMGA2 staining score (high/low) vs. tumor stage
(I, II, or III). J) Chi-Square test for data in (I) revealing a significant difference in staining inten-
sity, with stage III tumors exhibiting higher levels of HMGA2.
(TIF)
S3 Fig. Arid3a protein is unchanged while Hif3a protein is decreased in invasive areas of
adenocarcinomas. Immunohistochemical staining for Arid3a (A-D) and Hif3a (E-H), in sec-
tions fromWT small intestine (S.I.) (A, E), Lin28bLo/Let7IEC-KO S.I. (B, F), Lin28bLo/Let7IEC-KO
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adenoma (C, G), and Lin28bLo/Let7IEC-KO adenocarcinoma (D, H). All pictures are at same
magnification, with scale bar = 100 μm.
(TIF)
S4 Fig. E2f5 and Imp2 do not significantly affect colony forming potential while Arid3a,
Hif3a, Hmga2, and Igf2bp2 (Imp2) do not significantly affect stem cell marker expression.
A) Colony forming assay in WTmouse small intestine enteroids transduced with pTRIPz
(empty vector), pTRIPz-E2f5, or pTRIPz-Imp2 (Igf2bp2). Enteroids were treated with 100 ng/
ml doxycycline for 5 days, then dissociated into single cells. B-K) Q-RT-PCR for epithelial
stem cell markers in WT mouse small intestine enteroids transduced with pTRIPz vectors
expressing Arid3a, Hif3a, Hmga2, or Imp2 (Igf2bp2) and treated for 5 days with 100 ng/ml
doxycycline. Assays were performed in triplicate. Q-RT-PCR values in B-D were normalized to
Gapdh (Gapdh) and β-Actin (Actb).
(TIF)
S1 Table. Polyp and adenocarcinoma incidence inWT, Vil-Lin28bLo, Let7IEC-KO, Lin28bLo/
Let7IEC-KO mice.
(PDF)
S2 Table. Co-expression of Let-7 Targets HMGA2, ARID3A, IGF2BP2, PLAGL2, HMGA1,
HIF3A, E2F5, NR6A1, MYCN, and DDX19A with stem cell markers (LGR5, EPHB2,
ASCL2, MSI1, z-score threshold +/– = 1) in two human colon cancer datasets from TCGA
(http://www.cbioportal.org/) [37,69,70]. IGF2BP1 did not correlate with any stem cell mark-
ers.
(PDF)
S3 Table. Tumor incidence in Vil-Lin28bMed, and Vil-Lin28bMed/Hmga2+/IEC-KO mice sacri-
ficed at 9 months of age.
(PDF)
S4 Table. Primers used for RT-PCR.
(PDF)
S1 Methods. Supplemental experimental procedures.
(DOCX)
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